Edwards Lifesciences Corp (EW)

Payables turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Cost of revenue (ttm)	US$ in thousands	1,237,100	1,301,800	1,389,300	1,434,500	1,379,800	1,280,800	1,184,200	1,110,600	1,080,400	1,132,000	1,189,900	1,254,800	1,248,900	1,235,700	1,205,000	1,108,900	1,080,600	1,070,500	1,081,900	1,147,700
Payables	US$ in thousands	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Payables turnover		—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

December 31, 2024 calculation

Payables turnover = Cost of revenue (ttm) ÷ Payables
= $1,237,100K ÷ $—K
= —

The payables turnover ratio for Edwards Lifesciences Corp is not available for the periods indicated in the data provided. As the payables turnover ratio is a key financial metric that measures how efficiently a company is managing its payables, the lack of this data makes it challenging to evaluate the company's performance in terms of its ability to pay its suppliers in a timely manner.

The payables turnover ratio is typically calculated by dividing the cost of goods sold by the average accounts payable for a given period. A higher payables turnover ratio indicates that the company is paying off its suppliers more quickly, which can be a sign of good financial health and strong working capital management. Conversely, a low payables turnover ratio may signify inefficiencies in managing payables or strained relationships with suppliers.

Without specific data on the payables turnover ratio for Edwards Lifesciences Corp, it is difficult to assess how effectively the company is managing its accounts payable and whether there are any trends or patterns in its payment practices over time. It would be beneficial to have access to this information to gain a more comprehensive understanding of the company's financial performance.